Nordson

US · NDSN #983 by market cap Listed 1970

327.69 -6.53 -1.95%

Live - 5344 symbols - heartbeat 251s ago · 2026-10-08 07:01

Pre-market 327.69 0.00%

After-hours 327.69 0.00%

Overnight 323.37 -1.32%

Market cap: 18.25B
P/E (TTM): 33.17
P/B: 5.58
EPS: 8.51
Div yield: 1.00%
52W pos: 91%

Reader sentiment Are you bullish or bearish on NDSN?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 5.87, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +3.78% YoY

Margins

Gross margin: 55.16%
Operating margin: 25.94%
Net margin: 17.35%

Key ratios & quality

Enterprise value: 20.16B
Altman Z-Score: 5.87

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.25B	2.19B	2.12B	2.36B	2.59B	2.63B	2.69B	2.79B
Gross profit	1.24B	1.19B	1.13B	1.32B	1.43B	1.43B	1.49B	1.54B
Selling & admin expenses	733.75M	708.99M	693.55M	708.95M	724.18M	752.64M	812.13M	815.51M
Research & development	--	--	--	--	--	--	--	--
Operating profit	502.58M	483.11M	436.92M	615.13M	702.36M	672.76M	674.00M	724.27M
Pretax profit	448.52M	431.10M	301.49M	574.18M	649.28M	615.34M	585.48M	597.65M
Tax	71.14M	94.01M	51.95M	119.81M	136.18M	127.85M	118.20M	113.17M
Net profit	377.38M	337.09M	249.54M	454.37M	513.10M	487.49M	467.28M	484.47M
Basic EPS	7	6	4	8	9	9	8	9
Diluted EPS	6.40	5.79	4.27	7.74	8.81	8.46	8.11	8.51

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Revenue	682.94M	741.51M	751.82M	669.46M	740.85M	817.67M
Gross profit	373.90M	406.52M	423.47M	366.12M	404.08M	453.73M
Selling & admin expenses	205.15M	206.54M	208.87M	199.72M	206.87M	230.64M
Research & development	--	--	--	--	--	--
Operating profit	168.75M	199.98M	214.60M	166.41M	197.20M	223.09M
Pretax profit	138.77M	159.12M	182.90M	164.50M	141.17M	185.94M
Tax	26.37M	33.34M	31.27M	31.12M	23.86M	33.09M
Net profit	112.40M	125.78M	151.63M	133.38M	117.32M	152.85M
Basic EPS	2	2	3	2	2	3
Diluted EPS	1.97	2.22	2.69	2.38	2.09	2.73

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	884.10M	1.01B	1.02B	1.16B	1.13B	1.23B	1.28B	1.24B
Cash & ST investments	95.68M	151.16M	208.29M	299.97M	163.46M	115.68M	115.95M	108.44M
Inventory	264.48M	283.40M	277.03M	327.20M	383.40M	454.78M	476.94M	444.81M
Total assets	3.42B	3.52B	3.67B	3.79B	3.82B	5.25B	6.00B	5.92B
Total current liabilities	350.28M	477.63M	363.09M	445.39M	834.20M	582.09M	528.48M	758.26M
Short-term debt	33.29M	174.10M	60.95M	57.21M	413.18M	137.43M	126.25M	338.29M
Long-term debt	1.29B	1.08B	1.07B	781.71M	345.32M	1.62B	2.10B	1.68B
Total liabilities	1,970,271,000.00	1,935,402,000.00	1,915,665,000.00	1,631,831,000.00	1,526,000,000.00	2,653,710,000.00	3,068,774,000.00	2,874,110,000.00
Total equity	1.45B	1.58B	1.76B	2.16B	2.29B	2.60B	2.93B	3.04B
Retained earnings	2.49B	2.75B	2.91B	3.27B	3.65B	3.99B	4.30B	4.60B

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Total current assets	1.32B	1.33B	1.24B	1.25B	1.28B	1.33B
Cash & ST investments	130.16M	147.79M	108.44M	120.39M	102.02M	113.43M
Inventory	473.74M	459.25M	444.81M	451.14M	467.76M	469.31M
Total assets	6.06B	6.01B	5.92B	5.96B	5.96B	5.95B
Total current liabilities	516.64M	783.11M	758.26M	460.05M	491.88M	728.47M
Short-term debt	118.00M	359.25M	338.29M	76.53M	75.29M	227.09M
Long-term debt	2.12B	1.79B	1.68B	1.94B	1.84B	1.53B
Total liabilities	3,101,734,000.00	3,027,928,000.00	2,874,110,000.00	2,848,816,000.00	2,762,183,000.00	2,678,861,000.00
Total equity	2.96B	2.98B	3.04B	3.11B	3.20B	3.27B
Retained earnings	4.41B	4.50B	4.60B	4.69B	4.76B	4.87B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	504.64M	382.89M	502.42M	545.93M	513.13M	641.28M	556.19M	719.18M
Depreciation & amortization	108.41M	110.24M	113.30M	103.88M	99.92M	111.90M	136.18M	150.52M
Free cash flow	414.85M	318.65M	451.89M	507.62M	461.70M	606.70M	491.78M	661.12M
Dividends paid	-72.44M	-82.15M	-88.35M	-97.68M	-125.91M	-150.36M	-161.44M	-179.07M
Stock buybacks / issuance	-5.20M	-94.49M	-1.76M	-29.19M	-250.75M	-68.34M	-2.27M	-297.35M
Ending cash balance	95.68M	151.16M	208.29M	299.97M	163.46M	115.68M	115.95M	108.44M

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
Operating cash flow	119.17M	237.97M	202.91M	140.43M	180.67M	249.37M
Depreciation & amortization	37.58M	37.85M	38.07M	36.59M	36.32M	36.55M
Free cash flow	103.13M	226.41M	193.85M	122.92M	170.49M	236.75M
Dividends paid	-44.34M	-44.07M	-46.06M	-45.79M	-45.86M	-45.74M
Stock buybacks / issuance	-84.35M	-69.33M	-84.58M	-67.21M	-19.09M	-23.35M
Ending cash balance	130.16M	147.79M	108.44M	120.39M	102.02M	113.43M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	28.96	22.24	14.94	23.19	23.04	19.93	16.90	16.21
ROA %	11.04	9.72	6.94	12.17	13.48	10.75	8.31	8.13
ROIC %	15.11	13.26	9.40	15.46	16.89	13.98	11.00	10.91
5-year avg ROE %	29.78	28.72	26.32	23.76	22.47	20.67	19.60	19.86
EBIT margin %	22.09	21.80	15.73	25.39	25.93	25.67	25.07	25.14
FCF / sales %	18.40	14.52	21.30	21.49	17.82	23.08	18.28	23.68
Current ratio	2.52	2.12	2.81	2.62	1.36	2.11	2.41	1.64
Quick ratio	1.68	1.43	1.87	1.77	0.84	1.21	1.34	0.92
Debt / assets	38.80	35.80	33.98	25.10	22.52	35.47	38.67	35.36
LT debt / equity	89.21	68.62	67.52	41.42	19.49	66.41	74.83	57.63
Interest coverage	10.05	10.14	10.37	23.52	29.97	11.34	7.58	6.74
Revenue CAGR (3Y) %	10.11	6.65	0.87	1.57	5.69	7.41	4.43	2.53
Net income CAGR (3Y) %	21.36	7.43	-5.51	6.38	15.03	25.01	0.94	-1.90
FCF CAGR (3Y) %	27.56	5.19	16.58	6.96	13.16	10.32	-1.05	12.71

Line item	2025-04	2025-07	2025-10	2026-01	2026-04	2026-07
ROE %	15.54	15.59	16.21	17.47	17.14	17.76
ROA %	7.95	8.11	8.13	8.84	8.78	9.29
ROIC %	10.79	11.16	10.91	11.63	11.56	12.21
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	24.17	24.09	25.14	26.22	25.62	25.68
FCF / sales %	16.99	19.50	23.68	22.71	24.58	24.30
Current ratio	2.56	1.69	1.64	2.72	2.60	1.82
Quick ratio	1.46	0.94	0.92	1.50	1.44	1.05
Debt / assets	38.33	36.96	35.36	34.97	33.09	30.57
LT debt / equity	74.50	62.43	57.63	64.53	59.29	48.67
Interest coverage	6.50	6.21	6.74	7.41	7.74	8.44
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Industrial Precision Solutions is the largest reported line at 44.91% of revenue, across 3 reported segments.
No single line clears half of revenue; Medical and Fluid Solutions is next at 28.19%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Industrial Precision Solutions44.91%

Medical and Fluid Solutions28.19%

Advanced Technology Solutions26.89%

Quote time 2026-10-08 07:01:27 · For reference only, not investment advice and not tailored to your situation.